Pericardial Disease (ABIM Review)

picture this. A 45 year old patient has just hit the emergency department. He's clutching his chest, reporting this severe, sharp, totally unrelenting chest pain that radiates up to his trapezius ridge. Okay, so you're already sweating a little bit. Exactly. You pull up the ECG on your screen and there it is. Just diffuse ST segment elevations across multiple territories. And instantly your heart rate spikes. You're holding the phone, basically hovering your finger over the button to activate the calf lab for a code stemma. Yep, you're ready to call it. But then you pause. You decide to just walk down to the bedside first. Always a good move. Treat the patient not just the monitor. Exactly. So you walk in, you hand the patient a cup of water, and as he sits up and like leans forward to take a sip, he just lets out this massive sigh of relief. Wow. The pain just gets better. It suddenly improves just from leaning forward. So the dilemma is do you call the interventional cardiologist to rush him to the table or do you reach into your pocket for your stethoscope and order high dose and essays? I mean, that is really what separates just blindly following algorithms from practicing real clinical medicine. It really is. I'm Dr. Taylor. And I'm Dr. Griffin. And welcome to the A-BIM series on evidence at the bedside. We're going to spend this session completely dismantling the literature on paracardiol disease. We're going to move chronologically through the natural history of the condition, which is really mirroring exactly how you'll see it evolve on the wards, right? And how the boards will test it. Exactly. I've actually been looking forward to this one because the paracardium is just one of those structures we tend to totally ignore. Oh, completely, until it's, you know, actively trying to kill our patient. Right. So we'll start today with the acute inflammatory phase acute paracarditis. And then we'll explore what happens mechanically when that inflamed sac starts weeping fluid, which pushes the patient right into a paracardiol effusion. And eventually the absolute hemodynamic crisis of cardiac tamponate. Yeah, the pressure quicker phase. Yeah. And then finally, we'll fast forward maybe months or even years down the line to look at the chronic, fibiotic scarring phase. Constrictive paracarditis. Yeah. The rigid shell. And we're going to get incredibly granular here. Oh, absolutely. By the time we finish, you'll be equipped to really expertly navigate these clinical scenarios. You'll dodge those classic traps the ebim examiner's just love to set. And you'll be able to apply these evidence-based pearls directly to your patient care. So let's get back to that patient sitting on the edge of the bed in the ED. Right. The acute paracarditis case. The textbook clinical scenario is that sharp, severe, pleoretic chest pain. And it's highly positional. Like it gets significantly better when they sit up and lean forward. But it's just agonizing when they lie flat on their back. But, you know, I want to push on why that actually happens, like structurally. Yeah, let's break that down. Why does leaning forward do anything at all for a sac that encases the whole heart? You have to think about the regional anatomy, right? Where the paracardium is actually anchored. It's not just floating free in the chest cavity. Right. It's tethered. Exactly. It has really firm attachments to the sternum anteriorly and the diaphragm inferiorly. So when the patient is lying supine, gravity and the weight of the heart pull backward. That physical weight stretches that acutely inflamed anterior paracardium against the sternal and diaphragmatic tethers. Ouch. Yeah, that makes perfect sense. So sitting up and leaning forward literally relieves that mechanical tension. It does. And the quality of the pain that really sharp knife-like sensation that comes down to innervation. Right. The diaphragmatic plura shares its innervation with the frenic nerve. Exactly. Which perfectly explains why the pain so often radiates up to the trapezius ridge. Because the frenic nerve originates from C3, C4, and C5, right? Yep. C3, C4, C5 keeps the diaphragm alive. We all learned that one. Classic. And those exact same nerve roots supply sensory innervation to the shoulder and the neck area. So if a patient is complaining of chest pain that shoots up into their neck or their shoulder blade while taking a deep breath, I mean, they are handing you a massive diagnostic clue. A total gift on a silver platter. Now, the recent guidelines lay out five very specific criteria for diagnosing acute paracarditis. So we need to firmly identify at least two of these five, right? Right. At least two. The first is that typical positional chest pain we just talked about. The second is hearing a classic paracardial friction rub on osculation. The third is new characteristic ECG changes. Fourth is the presence of an inflammatory biomarker elevation. So specifically, that's the erytherocyte sedimentation rate or the the reactive protein. And then the fifth is a new paracardial effusion or definitive imaging that indicates paracardial inflammation. Right. Like seeing late gadolinium enhancement on a cardiac MRI. Okay. I really want to spend some serious time on the ECG analysis here. Yeah. Because on the boards, distinguishing this from an acute MI is literally life or death. Completely. The classic teaching we always hear is diffuse concave ST segment elevation. But what does diffuse really mean in a practical sense? Because I mean, a massive anterior stomach can look pretty diffuse if it's wrapping around the A-bex. That's a great point. Diffuse in this context means it explicitly ignores coronary artery vascular territories. Right. Because coronary artery supply very specific distinct wedges of the myocardium. Like the left anterior descending artery supplies the anterior wall and septum. So you look at leads v1 through v4. And the right coronary artery supplies the inferior walls. You're strictly looking at leads to 3 and avf. So if you see a true coronary occlusion, the ST elevation is just mathematically restricted to those boundaries. But in paracarditis, the inflammation is like a blanket over the entire heart. Exactly. So you're seeing ST elevations in leads that do not share a single coronary blood supply. You might see it in lead I, avl, v3 and lead 2 just all simultaneously. Right. And in an acute MI, you're also constantly scanning for reciprocal ST segment depression in the opposing leads. Yeah, because if the inferior wall is infarcting, the lateral leads are looking at the tail end of that injury vector. So they naturally show depression, but you don't get reciprocal ST depression in acute paracarditis. Well, except for one very notable exception, which the board's just test constantly. Uh, yes. Lead avr. It's like the lonely outcast of the 12 lead ECG just looking down from the right shoulder. It really is. And the pathophenomonic finding for acute paracarditis is actually PR segment depression in lead 2 and reciprocal PR segment elevation in lead avr. Okay. So I've memorized PR depression in lead 2 since like my second year medical school. But let's break down the actual electrophysiology of that. Yeah. Why is the PR segment shifting at all? It all comes down to the atria. You have to remember what the PR segment represents. Right. It represents the time between atrial depolarization and the start of intricular depolarization. Exactly. So the paracardium is inflamed and that inflammation very easily seeps into the superficial epicaridium. And the atria have incredibly thin walls compared to the thick ventricles. So they are highly, highly susceptible to this superficial inflammatory process, which basically creates an atrial current of injury. Oh wow. So just like a ventricular current of injury shifts the SK segment. An atrial current of injury shifts the PR segment. You nailed it. That's exactly it. The vector of atrial repolarization gets entirely altered by the injured tissue. And it most leads, particularly lead 2, which you know looks straight down the anatomical axis of the heart. This manifests as the PR segment physically dipping below the baseline. Yep. And because avr is sitting 180 degrees opposite to lead 2, it sees the exact inverse of that vector. PR segment elevation. Exactly. So if you see PR depression in lead 2 and PR elevation in avr alongside those diffuse ST elevations, you can very confidently lower your finger from that code stemmy button. That is such a satisfying physiological explanation. Okay, so let's move to the management algorithms. Let's do it. Say we confirm the diagnosis, we have the positional pain, the diffuse ST elevations, the PR changes. The literature is actually very clear on first line versus second line therapies here. But the standard of care has really evolved significantly over the last decade or so. It really has. If a patient comes in with an acute idiopathic or viral paracarditis, first line therapy is high dose aspirin or an NSAD like ID profen, given around the clock for one to four weeks. But crucially, we don't stop there anymore. No, we absolutely have to add Colchocene. We give it for three months for a first episode. I find Colchocene fascinating. I mean, we steal it from rheumatology where it's used for gout. Right. But how is an anti-gout medication fixing an acutely inflamed paracardium? It acts on the fundamental cellular machinery of inflammation itself. Okay, walk me through that. So Colchocene binds to tubulin. tubulin is the structural protein that makes up microtubules inside the cell. And when you disrupt those microtubules, you essentially paralyze the cell's internal transport system, right? Exactly. White blood cells, specifically neutrophils, rely really heavily on microtubules to crawl toward sites of inflammation. The process of chemotaxis. Right. So if you give Colchocene, the neutrophils essentially lose their physical ability to migrate into the paracarial space. They get frozen in their tracks. And the evidence shows that adding Colchocene significantly shortens the symptom duration. It reduces the rate of treatment failure. And honestly, most importantly, it drastically lowers the rate of recurrence. And recurrence is just the nightmare scenario for these patients. It's awful. They feel better. They stop their meds. And then three weeks later, they're back in the ED in absolute agony. Right. But what if they do fail that first line NSAID in Colchocene combo? What's the next step? The guidelines say we have to deeply phenotype the disease before just blindly choosing a second line agent. We need to categorize them into either an inflammatory phenotype or non-inflammatory phenotype. And that distinction dictates the entire clinical pathway. So an inflammatory phenotype means there is objective, systemic evidence of an active fire, essentially. Yes. They have fevers, their CRP is highly elevated, or if you get a cardiac MRI, you see intensely gadolinium enhancement. Which physically shows you the edema and hypermemia in that paracardiol tissue. Exactly. And if they fit this inflammatory bucket, your second line therapy needs to be an anti-interluchin one agent. Like your lanacect or anakin run? Yeah. And this is where the science has gotten really elegantly lately. These drugs target the inflamism directly. The inflamism. That's this multi protein complex inside immune cells that acts as like a master sensor for danger. Yeah. So if you're a third, whether by a virus or even just by tissue damage, it turns out interluchin one beta. Which is just a massive pro-inflammatory cytokine. It's the match that lights the fire. So by giving lanacect, which is essentially a decoy receptor, you trap that interluchin one before confuole the paracardiol fire. Wow. But what if they fall into the other bucket, the non-inflammatory phenotype? Right. So the patient has the pain, maybe they have the rub, but their CRP is stone-cold normal. And there are zero systemic signs of inflammation. That is the very specific scenario where you reach for glucocorticoids like prednisone at a moderate dose. And this is exactly where the classic board trap comes in. Oh, yes. They love this one. The examiners will tempt you to use steroids as a first-line agent for everyone with paracardi disorder. Because steroids fix inflammation, right? It seems so intuitive. It really does. But if you give steroids early, or at high doses in a patient who doesn't strictly need them, you are totally setting them up for failure. Because the rebound effect is incredibly severe. Right. Steroids rapidly suppress the inflammation. Sure. But they don't solve the underlying pathophysiologic trigger as cleanly as the NSAI, Davidi, and Coltucin combo does. So when you try to taper those steroids? The inflammation just wakes up angrier than before. And the patient's risk of recurrent paracardiitis just skyrockets. You really want to save glucocorticoids for that non-inflammatory phenotype. Or for patients who have absolute non-goshable contraindications to NSAI's and Coltucin? Like someone with severe end-stage renal disease. Or a pregnant patient where NSAI's are contraindicated, especially later in the pregnancy. Okay, so we've got the pharmacological treatment down. But a huge part of practicing medicine on the wards is triage. Triage is everything. Who gets to go home with a prescription for ibuprofen and Coltucin and who needs a bed upstairs? Because most patients with acute idiopathic paracardiitis can safely go home. Right. They can. But the literature identifies very specific high-risk features that absolutely mandate admission. And there's a great memory hook for this. Yes. I use this all the time. If the patient is not huge, slow, bleeding, or stubborn, you admit them. Okay, let's translate those memory hooks into actual pathophysiology for the listeners. Sure. Pretty straightforward. But why does a fever automatically buy them an admission? Because a high fever points away from a simple, self-limiting viral process. It points towards something much more destructive, like a bacterial, purulent paracardiitis. Which is rare, but it is catastrophically in habit. It can lead to rapid-loculation, tamponade, and just a massive systemic inflammatory response. Yeah, you definitely need them in-house for blood cultures, close monitoring, and potentially aggressive IV antibiotics. Next on the list is huge. This refers to a large paracardiol effusion. On an echocardiogram, the evidence defines that as an echo-free space greater than 20 millimeters during diastole. Right. Or, obviously, any clinical evidence that they're trending toward tamponade. We'll talk extensively about tamponade shortly. And a fusion of that size means the paracardiome is highly, highly reactive. It's producing a massive amount of fluid, and their hemodynamics could just collapse at literally any moment. Okay, then we have slow. This means a subacute onset. Right. Because the classic viral paracardiitis patient can usually tell you exactly when the pain started. They'll say, "I woke up Tuesday morning and it felt like an ice pick in my chest." But if a patient comes in and says, "You know, my chest has felt sort of heavy and achy for about three weeks. I've been sweating at night, and I've been losing some weight." That insidious subacute timeline is a massive red flag. You have to start worrying about tuberculosis, especially depending on their demographic and travel history. Or you worry about a malignant paracardiolifition, maybe from a primary lung or breast cancer. Or even an insidious autoimmune process like systemic lupus erythematosis. Exactly. These require incredibly complex workups that just can't be managed with a quick ER discharge. The fourth one is bleeding, which really covers any patient on oral anticoagulation. Warpherin, a pixaband, riveroxaband. This one always makes me sweat as a clinician. Bo-Me too. Because the inflamed paracardiome is incredibly vascular. It's angry, it's hyperemic, and it's very friable. So, if you have a patient whose blood is thinned, the literal physical friction of the heart beating against that friable tissue can cause micro-tears. They're at a profoundly elevated risk of bleeding directly into the paracardiol space. A simple benign serious effusion suddenly turns into a rapidly expanding hemorrhagic tamponade. It's terrifying. And finally, the last one is stubborn. Which is a failure to respond to one full week of appropriate, high-dose NSA therapy. If they are perfectly compliant with their meds and they are still in excruciating pain seven days later, the initial diagnosis might just be wrong. Or they have a highly resistant inflammatory phenotype. Either way, they need to come into the hospital for a much deeper diagnostic dive. Which perfectly sets up one of the most dangerous and commonly tested traps on the A-Bim exam. The post-emi-trap. Listeners pay very close attention to this one. Here is the scenario they will give you. A patient comes in with a massive anterior stemmy. They undergo a successful PCI, they get a stent in their LAD. Standard stuff so far. But, one or two days later, they are recovering in the cardiac ICU and they suddenly complain of sharp, pleuritic chest pain. You go to the bedside, you listen to their chest, and you hear a distinct scratchy paracardiol friction rub. They have developed peri and pharcoparocarditis. And the exam will give you five options for medication and they will absolutely try to bait you into clicking ibuprofen, endomethocin, or prednisone. And if you click any of those, you've killed the patient on paper. You really have. Let's play devil's advocate. Why? We just spent 10 minutes talking about how NSIs are the gold standard for peri-carditis. Why is the scenario any different? You have to step back and look at what is actively happening to the myocardium itself in that moment. The patient just had a transmural infarction. A piece of the heart muscle literally died. The body's immediate biological response is to send in macrophages to clear out the necrotic debris. And then crucially, fibroblast migrate in to lay down at dense collagen matrix. The heart is desperately trying to form a stable scar to patch that dead zone. Exactly. And it needs that scar to maintain the structural integrity of a ventricular wall so it can withstand the incredible pressure of the system. Right. Because the left ventricle pumps with a huge amount of force. Right. And NSIs and glucocorticoids powerfully impair that precise healing cascade. They inhibit the inflammatory signals necessary to recruit those fibroblast. So if you give high dose NSIs to treat the perian-farked pericarditis, you are actively preventing the myocardium from healing. The scar becomes thin, weak, and disorganized. And over the next few days, as the left ventricle forcefully contracts against that high pressure, that weakened necrotic wall can literally blow out. You cause a catastrophic left ventricular free wall rupture. Or a ventricular septal defect. Both of which carry just a bismomortality rate. So if I have a post-MI patient screaming in pain from a pericardial rub and I can't use NSIs and I can't use steroids, what on earth is the correct move? The only acceptable therapy in the literature for pericarditis is high dose acetaminophen and aspirin. Which always trips people up. Aspirin is technically an NSI ID, right? It inhibits cyclooxygenase. Why does an aspirin cause the ventricular wall to rupture? It's purely a matter of degree and mechanism. And irreversibly inhibits platelets, sure. But at the doses used for secondary prevention after an MI, it doesn't suppress the myocardial tissue healing pathways as profoundly as a heavy hitter like ibuprofen or endomethocin. Okay. Plus, the patient absolutely must be on aspirin anyway to keep their brand new stent open. Exactly. And here is a really nuanced point for the boards. The literature shows that culticine, despite being our wonder drug for viral pericarditis, does not provide a statistically significant benefit in this specific perian-fark scenario. Really? It doesn't help. Nope. It doesn't seem to alter the clinical course at all. So you stick to acetaminophen for the pain and you maintain their daily aspirin. That is such a crucial distinction. Okay. Let's talk about the physical exam before we move on. Yeah. We keep mentioning the pericardial friction rub. It is one of the diagnostic criteria, but actually finding it on the boards can be incredibly frustrating. It is notoriously transient. The 19 will probably document a loud rub at 4-BUT-AM, and when you round with the attending at 9-AM, it's completely vanished. It is so elusive. The technique you use at the bedside is critical to actually capturing it. You can't just, you know, throw your stethoscope on a soupine. patients' chest while they are casually chatting with you. No, you really have to manipulate the anatomy. Walk us through the ideal osculation technique. First, have the patient sit perfectly upright. Then have them lean forward. Which, as we discussed, utilizes gravity to drop the heart anteriorly. Right. It brings the inflamed paracardial layers into the closest possible contact with the chest wall. Then you take the diaphragm of your stefoscope, because you were listening for high frequency sounds, and apply it really firmly to the left lower sternal border. And then the most crucial step. You instruct the patient to exhale completely and hold their breath at end expiration. Why end expiration specifically? Because the lungs sit directly between the heart and the chest wall. When you inhale, the lungs inflate and expand over the heart, which creates this thick, acoustic buffer of air that completely muffles high frequency sounds. Oh, that makes sense. So by forcing the patient to exhale, you essentially deflate that buffer. Exactly. You minimize the lung volume, putting your stefoscope as close to the paracardium as physically possible. And what does it actually sound like? The classic textbook description is like walking on dry, crunchy snow, or two pieces of rough leather rubbing together. It's harsh, scratchy, and very superficial. But the acoustic mechanics of it are what the boards really care about. Right. During normal sinus rhythm, a classic paracardial friction rub has three distinct components. And they correspond perfectly to the maximal movements of the heart within the paracardial sac. Let me break them down. Think about the cardiac cycle. The first movement that causes friction is atrial cystal. The atrier contract, shifting physically against the inflamed paracardium. That's component number one. The second component is ventricular cystal. The massive left and right ventricles contract and fiercely twist. This is the largest mechanical movement of the entire cardiac cycle. So this component of the rub is usually the loudest. And the third component happens in diastole, specifically early rapid ventricular filling. The mitral and tricuspid valves pop open, and blood just rushes into the ventricles, causing them to rapidly expand outward against the paracardium. That sudden outward expansion creates the third friction sound. Understanding those three mechanical phases, atrial cystal, ventricular cystal, and early diastolic filling is exactly how you differentiate it from a plural friction rub. Right, because a patient with pneumonia or a pulmonary embolism might have a plural rub. But a plural rub only has two components, and they're strictly linked to inspiration and expiration. And if you ask a patient with a plural rub to hold their breath, the sound disappears completely, right? Because the lungs stop moving. Exactly. But if you ask a patient with a paracardial rub to hold their breath, the scratchy three component sound completely persists, because the heart doesn't stop beating just because you stop breathing. What a fantastic bedside purl. OK, let's evolve the pathology here. We've discussed the inflamed dry rubbing paracardium. But an inflamed tissue is an angry tissue, an angry tissue weeps fluid. Capillary permeability increases, and plasma just starts leaking right into the paracardial space. We're moving from the acute inflammatory stage into a paracardial effusion. And if that fluid accumulates fast enough, we enter the absolute pressure cooker environment of cardiac tamponade. This is where understanding hemodynamics becomes your absolute best friend. Cardiac tamponade is not defined by the sheer volume of fluid. It is strictly defined by pressure. It occurs when the fluid fills the paracardial space. And the inter-paracardial pressure rises to the point where it completely exceeds the inter-cardiac filling pressures. Let's break that down because it's vital. The right atrium normally operates to very low pressure, maybe two to six millimeters of mercury. Right. So if you slowly accumulate a massive two-liter paracardial effusion over, say, six months due to a slow-growing malignancy. The paracardium is time-distretion remodel. The inter-paracardial pressure might stay low, so the right atrium can still fill relatively normally. But if a patient takes a knife to the chest or bleeds from an aortic disception, even just 150 milliliters of blood rapidly filling the sack in five minutes will cause the inter-paracardial pressure to violently spike to 20 millimeters of mercury. Because the paracardium just doesn't have time to stretch, it's on the steep portion of its pressure volume curve. Suddenly, the pressure outside the heart is 20, and the pressure trying to fill the right atrium is only five. And the physics are incredibly simple. Fluid flows from high to low pressure. The blood in the venocava simply cannot enter the right atrium against that massive gradient. The heart is basically being crushed from the outside in. It can't relax and diastole, which means it can't fill. And if it can't fill it, it is absolutely nothing to pump out. Your stroke volume plummets, cardiac output crashes, and you enter profound, obstructive shock. The classic clinical triad we all memorized is vex triad, right? Hypertension, muffled heart sounds, and an elevated jugular venous pressure. But relying on vex triad in modern medicine is really dangerous. The board's demand a much deeper understanding of the hemodynamics. So let's talk about the absolute hallmark bedside finding. Pulsis paradoxis. Pulsis paradoxis is defined as a fall in systolic blood pressure of greater than 10 millimeters of mercury during normal inspiration. I want to stop here for a second, because the name itself is super confusing. Why is it called a paradox? What is paradoxical about it? It's a purely historical term. When it was first described, the physician could hear the heart beating regularly through the stethoscope. Right. But when they felt the radial pulse, the pulse seemed to just vanish entirely during inspiration. Oh. So the paradox was that the heart was clearly beating, but the peripheral pulse was inexplicably disappearing. Exactly. Today, we measure precisely with a blood pressure cuff, looking for that drop of more than 10 points. To understand why this systolic pressure drops on inspiration, you really have to understand the physiological concept of intricular interdependence. And this is truly one of the most elegant mechanisms in all of cardiovascular medicine. It really is. So the paracardium is a fibrous sac. Normally, it's pliable enough to let the ventricles expand independently. But in tamponade, the fluid makes it a tight, non-compliant, totally unyielding shell. The total volume inside that sac is fixed. It cannot expand another millimeter. Keep that fixed volume in mind, listeners. Now, what happens when a patient takes a deep breath in? The diaphragm drops generating negative intra-therastic pressure, which acts like a vacuum. It sucks Venus blood from the systemic circulation straight into the right side of the heart. So the right atrium and right ventricle suddenly fill with this extra volume of blood. The right ventricle wants to expand outward to accommodate this extra blood. But it can't. It hits that solid wall of high pressure tamponade fluid. It is nowhere to go outward. So it takes the path of least resistance. It pushes inward. The right ventricle physically bulges the intraventricular septum directly into the left ventricle. This is the crux of ventricular interdependence. The right ventricle literally steals space from the left ventricle. Because the septum is bowing into the left ventricular cavity, the left ventricular end diastolic volume is severely compromised. It just cannot fill adequately. And according to the Frank-Starling mechanism, if you decrease the end diastolic volume, you inevitably decrease the stroke volume. The left ventricle simply has less blood to pump forward. So the systolic blood pressure drops significantly on inspiration. That is a positive pulses paradoxes. It's just brilliant physiology. Now, when you detect a pulses paradoxes, your immediate next step is an echocardiogram. And the echocardiographic findings are incredibly high yield for the boards. The evidence outlines three major signs of tamponade. You absolutely need to memorize. First is an inspiratory decrease in mutual inflow velocity of more than 25%. Which makes perfect sense based on exactly what we just discussed. Right. The mitral inflow velocity is just the ultrasound equivalent of measuring the blood entering the left ventricle. If the septum is bowing in during inspiration, less blood enters the LV. So the velocity of flow across the mitral valve drops by over 25%. It is literally the Doppler manifestation of pulses paradoxes. The other two echo findings involve chamber collapse. This is where you see the right ventricular wall collapsing inward and the right atrial wall collapsing inward. But here is the must-no-purl that will save you points on the exam. You must understand the specific timing of this collapse within the cardiac cycle. You will see right atrial collapse and late diastole and right ventricular collapse and early diastole. No, I really want to dig into that timing because it feels so counterintuitive at first glance. Let's look at the right atrial. OK. Late diastole is when the atrial are actively contracting the atrial kick. Why would a chamber collapse at the exact moment it is actively squeezing muscle? Huh, it's not collapsing during the squeeze. It collapses immediately after the peak of that squeeze right as it begins to relax. Oh, I see. It's entirely about pressure gradients. The right atrium has the lowest baseline pressure of any cardiac chamber. So during late diastole, after the active contraction, the atrium begins to relax. And at that exact millisecond, the pressure inside the right atrium hits its absolute nature. It is the lowest pressure point in the entire cardiac cycle. So it's an issue of profound vulnerability. Because the surrounding intrepair cardio fluid pressure is exceptionally high, it finally overcomes the internal right atrial pressure precisely at that moment of maximum relaxation. In late diastole, the fluid just pushes the atrial free wall inward, causing it to buckle or invert. Exactly. Now look at the right ventricle. The right ventricle has a much thicker wall and slightly higher. internal pressures than the atrium, so it can hold its ground a bit longer. But when does the right ventricle reach its most vulnerable, lowest pressure state? In early diastole. Right after the pulmonary valve closes, the ventricle begins to actively relax isovolumetric relaxation. The pressure inside the ventricle rapidly drops to near zero before the tricuspid valve even opens to let blood in. Right. And at that exact moment of early diastolic relaxation, the external tamponade pressure totally overwhelms the internal ventricular pressure and the free wall of the right ventricle buckles inward. And the longer the duration of that chamber collapse, specifically if the right atrium remains buckled inward from more than one third of the entire cardiac cycle. The more hemodynamically significant in life threatening the tamponade is. We should also touch on the ECG findings for a large effusion or tamponade. Beyond the compensatory sinus attack of cardiac, the classic board finding is electrical alternates. You look at the rhythm strip and you see a cyclic beat-to-beat shift in the amplitude of the QRS complex. One QRS is tall. The next one is short. The next one is tall again. The visual analogy here is just striking and really helps lock it into memory. Imagine the heart as a pendulum swinging back and forth with an massive fluid filled balloon. Because there is so much fluid, the heart physically shifts its anatomical position within the sac with every single contraction. It's basically doing front flips in the fluid. Exactly. Because the electrical axis of the heart is physically moving relative to your stationary ECG electrodes pasted on the patient's chest wall, the electrical vector changes. On beat one, the apex swings closer to the electrode, so the QRS looks tall. On beat two, the heart swings away so the QRS looks short. That physical beat-to-beat oscillation is electrical alternates. Now, I want to warn everyone about a major, incredibly dangerous trap on the wards and the boards. The normal blood pressure trap. Oh man, this is a big one. Do not let a normal systolic blood pressure deter you from calling for an urgent echo if the clinical picture suggests tamponade. This cannot be overstated. BExTryad requires hypotension, but if you wait for hypotension, you might be too late. Let's walk through why a patient in tamponade might actually have a blood pressure of 130 over 80. Early in the course of tamponade, as the stroke volume begins to fall because the heart can't fill, the body's bare receptors sense that drop in cardiac output. The brain mounts a massive, intent, adenergic, catacolamine surge. The sympathetic nervous system goes into absolute overdrive. And that sympathetic surge does two huge things. It causes profound tachycardia trying to maintain cardiac output by simply beating faster. And it causes severe peripheral vasoconstriction, clamping down on the arterials to skyrocket the systemic vascular resistance. Blood pressure is just cardiac output multiplied by systemic vascular resistance. So if the stroke volume is dropping, but the body intensely clamps down the blood vessels. The blood pressure will read as completely normal or even elevated in the early stages. If you see a patient with a sky high JVP up to their earlobes, muffled heart sounds, and a sinus tachycardia of 125, but their blood pressure is fine, do not walk away. They are compensating through sheer adenergic willpower. They are teetering on the edge of a hemodynamic cliff. Once the exhaust that catacolamine reserve or God forbid, if you accidentally give them a medication that blocks their heart rate like a beta blocker, they will crash rapidly and irreversibly into profound obstructive shock. Another subtle trap involves bright heart catheterization tracings. Sometimes the boards will show you the central venous pressure or CVP tracing of a patient in tamponade. A normal CVP tracing has very distinct waves, AC, V waves, and X and Y descents. But in tamponade, the classic finding is a blunted or completely lost Y descent. To understand that, you have to know what the Y descent represents physically. The A descent represents the rapid, passive emptying of blood from the right atrium down into the right ventricle. The exact moment the tracuspid valve opens in early diastole. Normally the right ventricle is relaxed and empty, so the blood falls rapidly into it, and the pressure in the atrium naturally drops, creating that Y trough on the tracing. In tamponade, what is the right ventricle doing? It's being actively crushed by external fluid pressure. It cannot relax. It is stiff and compressed. Therefore when the tracuspid valve opens, the right atrium cannot empty passively into the ventricle. The blood hits a high pressure wall. Because the blood can't rush out of the atrium, the pressure doesn't drop, and the Y descent just completely disappears from the monitor. So how do we translate all of this pathophysiology into actual bedside management? The definitive treatment for cardiac tamponade is mechanical. You have to remove the fluid. That means an emergent paracardiocentesis with a needle, or calling the surgeons for a paracardial window to drain it into the plural space. But let's be realistic here. You're the resident. You've called cardiology, but they are 15 minutes away. Your patient's compensatory mechanisms just failed. Their blood pressure is 60 over 40. They are altered, and they are actively crashing. What is your immediate, temporizing bridge to keep them alive until that needle arrives? It is intravenous, normal saline. You need to rapidly administer a fluid bolus. My first instinct, honestly, when I see a patient in heart failure with an elevated JVP, is to reach for a diuretic, like pyrrosmide. If the heart is failing, why on earth are we giving massive amounts of 5e fluids? Because tamponade is not a failure of the heart muscle itself. It is a failure of preload and pressure gradients. The right side of the heart is collapsing because the external inter-paracardial pressure is higher than the internal inter-cardiac filling pressure. Think of it as a battle of pressures. The fluid outside is pushing in at 20 millimeters of mercury, and the blood inside is pushing back out at 10. The outside is winning. Right. So by slamming the patient with a rapid bolus of IV fluids, you are artificially driving up the central venous pressure. You are trying to increase the right-sided filling pressures from 10 up to, say, 22. If you can make the internal pressure higher than the external paracardial fluid pressure, you literally pop the right ventricle open. You essentially stent it open with fluid. Exactly. You stent it open so it can finally accept blood and generate a stroke volume. Giving a diuretic would lower the internal filling pressures, causing the heart to collapse completely and instantly killing the patient. Giving foovie fluid is purely a temporizing measure. I mean, you won't fix the underlying problem, but it can buy you the 15 minutes you desperately need to get the paracardiocentesis tray set up. Okay, let's look down the timeline. What happens months or even years later? Say the patient had an acute viral paracardiidus, maybe a small effusion, and they eventually recovered. The fluid resorbs. The acute inflammation dies down. But it doesn't always heal cleanly. Sometimes it leaves behind a devastating legacy, a thick, rigid, fibiotic, and heavily calcified shell surrounding the heart. The paracardium turns from a thin, pliable membrane into something basically resembling a medieval breastplate. We've arrived at Constrictive Paracardiidus. Constrictive paracardiidus is a masterclass in indolent, insidious progression. The clinical presentation is essentially severe, intractable, right-sided heart failure. Because the right heart is encased in this unyielding shell, it simply cannot stretch to accommodate venous return. The blood just backs up. The patient presents with profound peripheral edema, massive acytes that might even mimic liver cirrhosis, hepatomegaly, and debilitating fatigue due to fixed, low cardiac output. And that brings us to the diagnostic hallmark on the physical exam. The Kusmol sign. Let's contrast this directly with pulses paradoxes, because examiners love testing the difference between the two. Pulse's paradoxes is a drop in blood pressure on inspiration. Kusmol sign is evaluated by looking at the patient's neck veins, the jugular venous pulse during inspiration. Normally, when you take a deep breath, you generate that negative intrathoracic vacuum we talked about. It draws blood from your head and neck down into your right atrium. So a normal, healthy person's JVP should fall or collapse when they breathe in. But in constriction, the right heart is trapped in a calcified box. It cannot stretch to accept that extra surge of venous blood. So in the patient breathes in, all that blood rushes down the superior venicava. It's a rigid wall at the right atrium and literally has nowhere to go. It backs up instantaneously into the jugular veins. The JVP fails to fall and paradoxically, it actually rises and distends further during inspiration. That visual rise in the neck veins is the Kusmol sign. If you suspect constriction based on the Kusmol sign and the acytes, you will eventually take that patient to the calf lab for a right heart catheterization. The hemodynamic tracings in constriction are unforgettable. And they are virtually guaranteed to show up on your boards. The classic finding in the right ventricle pressure tracing is the square root sign, also known as the dip and plateau waveform. Let's break down the physics of the square root sign and contrast it with tamponate again. Intamponate, we said the adescent is blunted or lost because the right ventricle is crushed and cannot relax to accept blood. But in constriction, the edescent is exceptionally prominent. Why is the edescent huge in constriction but totally missing in tamponate? It comes down to the health of the myocardium itself and the timing of the compression. In tamponate, the fluid pressure compresses the heart throughout the entire cardiac cycle. But in constriction, the rigid shell only limits the absolute volume the heart can reach. The myocardium itself is perfectly healthy, it's not diseased, it wants to relax. So in early diastole, when the tracuspid valve opens, the right ventricle recoils and springs open enthusiastically. Right, it relaxes powerfully creating a map massive suction effect. Blood rushes rapidly and unimpeded into the right ventricle. That rapid, deep emptying of the atrium creates a steep, prominent edicent that is the dip. But the ventricle is filling rapidly until it reaches its maximum volume, and then it suddenly hits that unyielding, calcified, pericardial shell. And it hits it hard, the rapid filling starts abruptly. It's like a car hitting a brick wall. The pressure inside the ventricle shoots up, and then just flat lines for the rest of the diastole, because no more blood can possibly enter. That sudden flat line is the plateau. The steep dip, followed by the flat plateau, looks exactly like a mathematical square root symbol on the monitor. And that sudden, violent halt of ventricular filling has an actual acoustic correlate that you can hear with your stethoscope at the bedside. It is called the pericardial knock. Differentiating diastolic sounds is an incredibly high-yield board concept. The literature provides a very clear framework for this. The pericardial knock is a high-frequency, sharp sound heard in early diastole, shortly after the S2 heart sound. It is heard widely throughout the pericardium. Physiologically, it is literally the acoustic shockwave of the expanding ventricle smashing into the calcified pericardium. You absolutely have to know how to differentiate the knock from other diastolic sounds. The boards will give you an audio clip or text description, and you have to pick the pathology. First, how do you differentiate it from the opening snap of mitral stenosis? The opening snap is also high-frequency and occurs in early diastole. But the opening snap is heard best localized at the apex and left lower-sternal border. More importantly, it is almost always accompanied by a loud, booming S1 and a low-pitched, rumbling diastolic murmur. The pericardial knock doesn't have that accompanying rumble. You also have to differentiate it from a tumor plop. A tumor plop occurs with a massive atrial mixoma that swings on a stalk. When the mitral valve opens, the tumor plops through the valve orifice, literally obstructing flow. The tumor plop is a low-frequency sound unlike the high-frequency knock. It's heard best at the apex, and a huge clinical clue is that the sound and the patient's symptoms are highly positional depending on how gravity pulls that tumor mass. But finally, differentiate the knock from a standard S3 gallop which you hear in volume overload or severe systolic heart failure. And S3 is a very low-frequency dull, thudding sound. It is heard best at the apex using the bell of your stethoscope, specifically while the patient is rolled onto their left lateral de-cubitus position. The pericardial knock is high-frequency and heard with the diaphragm. That frequency difference high versus low is your absolute key to answering the question correctly. If you've heard the knock and you suspect constriction, what is the best initial imaging pearl to actually confirm it? You start simple, a chest x-ray, particularly the lateral view, or a non-contrast CT scan of the chest. If you see partial or circumferential pericardial calcification, it is a slam-down diagnostic clue. The CT scan will clearly show a bright, dense, white ring of calcium just tightly encasing the myocardium, which brings us to the ultimate arguably the most difficult board trap in all of cardiovascular medicine, distinguishing constrictive pericarditis from restrictive cardiomyopathy. This is the separator question that determines if you truly understand hemodynamics. Because they look completely identical on the surface. You have a patient presenting with severe, right heart failure, massive at sites, peripheral edema, and elevated JVP, and a completely normal left ventricular rejection fraction. It could be an amyloid infiltrating the heart muscle causing restriction or a calcified pericardium causing constriction. How do you tell them apart? The boards will demand that you know this. The answer lies in tissue Doppler, echocardiography, and simultaneous right and left heart catheterization. Let's start with tissue Doppler. Normal Doppler looks at the velocity of blood flow. Tissue Doppler looks at the actual physical speed of the heart muscle moving. We are specifically looking at the E-prime velocity, which measures the speed of myocardial relaxation at the mitral annulus during early diastyl. Let's apply the pathophysiology. In restrictive cardiomyopathy, say cardiac amyloidosis, the disease is inside the muscle itself. The myocardium is heavily infiltrated with stiff amyloid fibrosis or severe fibrosis. The muscle is inherently diseased and rigid. It cannot relax properly. Therefore tissue Doppler will show severely impaired or reduced myocardial relaxation velocities. The E-prime will be low. Using constrictive paracarditis, the muscle fibers themselves are totally normal. The problem is exclusively the cage around them. Because the paracardiocage limits the outward expansion, the heart compensates by relying heavily on longitudinal expansion lengthening base to apex. The healthy myocardium relaxes and recoils beautifully in that longitudinal direction. So tissue Doppler in constriction shows unimpaired, normal, or sometimes even paradoxically enhanced myocardial relaxation velocities. The E-prime will be high. A high E-prime means constriction. A low E-prime means restriction. Now what if they give you the calf lab data? You are looking for our old friend, ventricular interdependence. If you perform a simultaneous right and left heart catheterization in a patient with constriction, you put a pressure catheter in the right ventricle and one in the left ventricle and you just watch what happens when they breathe. You will see a profound discordance in pressures during respiration. We talked about this mechanism earlier with pulses paradoxes. Because the total volume of the heart is fixed by the calcified shell, the right and left sides basically have to fight for space. On inspiration, the right ventricle fills and its pressure rises. It pushes the septum over, compromising the left ventricle, causing the left ventricular pressure to drop simultaneously. The pressure tracings literally move in opposite directions. One goes up the other goes down. That is discordance. And it is the absolute hemodynamic hallmark of constriction. Now look at restrictive cardiomyopathy. In restriction, the stiff, infiltrated muscle prevents the septal shifting. The septum is simply too rigid to bow back and forth. Because there is no fixed external cage limiting the total volume, both ventricles are exposed to the same changes in intra-therasic pressure. When the patient breathes in, the right and left ventricular pressures rise and fall together. They move in the exact same direction. That is concordance. This is concordance means constriction. Concordance means restriction. Let's finalize our discussion with the management workflow for constrictive paracarditis. The historical teaching was that if a patient has constriction, the only option is to send them immediately to the operating room to crack their chest. But the literature has evolved significantly on this. It has, and it highlights a critical life-saving distinction between chronic, fixed constriction and transient inflammatory constriction. If a patient has chronic, heavily calcified constrictive paracarditis, maybe they had radiation therapy to the chest 15 years ago for Hodgkin's lymphoma. And now they have a dense calcified shell with no signs of active inflammation. The definitive treatment is surgical paracardial stripping. It's a complete paracardiac to me performed via a median sternotomy. The surgeon literally has to peel the calcified shell off the beating heart. It is a massive, highly invasive surgery with significant morbidity and mortality. You want to avoid that surgery if at all possible. So the key clinical parole is systematically evaluating for active inflammation before sending them to the surgeon. You check in the ESR and the CRP. You get a cardiac MRI, specifically looking for paracardiolidema and intense lead ghettelineum enhancement. If the inflammatory markers are highly elevated or the MRI shows a hot, a dimadisk paracardium, the patient doesn't have chronic fibrosis yet. They have transient or subacute effusive constrictive paracarditis. The rigidity is actually coming from the intense inflammatory edema, not permanent calcification. The clinical parole here is that you must give these patients a trial of high dose medical anti-inflammatory therapy first. You hit them with NSA ads, coltucine and sometimes steroids are anachyndra for two to three solid months. Because in many of these cases, if you treat the inflammation medically, the adema resolves, paracardium softens and the constrictive physiology completely reverses. You cure their heart failure with pills and you spare the patient an incredibly dangerous open heart surgery. It is a phenomenal testament to the power of understanding the underlying pathophysiology and applying targeted medical therapy. And that actually brings us to the end of our chronological roadmap through paracardiol disease. We have covered the acute inflammatory burn, the acute pressure crisis of tamponade, and the chronic, fibrotic shell of constriction. Before we sign off, let's explicitly summarize the absolute must-no takeaways from the evidence we discussed today. First, remember the post-MI paracarditis trap. If a patient develops perian-fark paracarditis days after a stemmy, you must use high-dose acetaminophen and daily aspirin. Never use high-dose NSA's or glucocorticoids because they will impair collagen scar formation and precipitate a catastrophic ventricular free wall rupture. Second, cement those tamponade hemodynamics in your mind. Look for the blunted or losty descent on the right heart cath because the right atrium cannot passively empty against the high intrepair cardio fluid pressure. Look for electrical alternans on the ECG caused by the heart physically swinging like a pendulum in the fluid. And always remember the normal blood pressure trap. Early in tamponade, the extreme sympathetic catacolamine surge can elevate vascular resistance and completely mask the dropping stroke volume, making the blood pressure look falsely reassuring. Third, when you are faced with the ultimate board question of distinguishing constriction from restriction, look closely at the tissue Doppler and the cath tracings. features preserved or even enhanced myocardial relaxation, a high E prime, along with marked ventricular interdependence, shown by discordant pressure changes during respiration. Restriction will show impaired myocardial relaxation and concordant pressures. Those three physiological frameworks alone will carry you through countless board questions and they will absolutely guide your management during those late night admissions on the wards. Thank you so much for joining us for this session of the AIMM series. If you found this discussion valuable, please like, share and subscribe to Evidence at the Deadside. It really helps us continue to bring you these high yield, physiologically driven clinical breakdowns. Please do like, share and subscribe. Take these pearls straight to the wards, apply them to your patient care, and as always, keep challenging yourselves to understand the intricate why behind every clinical presentation. As you head back to the floors, consider this final thought. We just spent a long time discussing the life-threatening hemodynamic crises caused by the paracardium. Make an inflame, it can crush the heart with fluid, it can encase it in stone. But evolutionarily speaking, patients born entirely without a paracardium. A rare condition called congenital absence of the paracardium often live completely asymptomatic normal lives. They run marathons, they have children totally unaware that the sack is even missing. It really makes you wonder if the heart functions perfectly well without it? Why did nature give us this fibrous sort of damnakly is hanging over our chests in the first place? time, keep thinking critically.